Merck to Host Investor Teleconference to Discuss ESMO 2016 Highlights
September 20, 2016 7:30 am ET
Merck (NYSE: MRK), known as MSD outside the United States and Canada,
will host a teleconference for investors following the presentation of
data at the European Society for Medical Oncology (ESMO) 2016 Congress
in Copenhagen, Denmark, Oct. 7 – 11. The call will take place on Sunday,
Oct. 9 at 6:30 p.m. CEST (12:30 p.m. EDT). Company executives will
provide an overview of data presented and address questions. Investors,
journalists, and the general public may access a live audio webcast of
the call on Merck’s website at http://investors.merck.com/investors/webcasts-and-presentations/default.aspx.
A replay will be available at www.merck.com.
Institutional investors and analysts can participate in the call by
dialing (706) 758-9927 or (877) 381-5782 and using ID code number
84673546. Members of the media are invited to monitor the call by
dialing (706) 758-9928 or (800) 399-7917 and using ID code number
84673546. Journalists who wish to ask questions are requested to contact
a member of Merck’s Media Relations team at the conclusion of the call.
About Merck
For 125 years, Merck has been a global healthcare leader working to help
the world be well. Merck is known as MSD outside the United States and
Canada. Through our prescription medicines, vaccines, biologic
therapies, and animal health products, we work with customers and
operate in more than 140 countries to deliver innovative health
solutions. We also demonstrate our commitment to increasing access to
health care through far-reaching policies, programs and partnerships.
For more information, visit www.merck.com
and connect with us on Twitter,
Facebook,
YouTube
and LinkedIn.
Merck
Media:
Pamela Eisele, 267-305-3558
Kim Hamilton, 908-740-1863
or
Investors:
Teri Loxam, 908-740-1986
Amy Klug, 908-740-1898
